Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Maria Teresa Pirrotta"'
Autor:
Francesco Zaja, Marta Lisa Battista, Maria Teresa Pirrotta, Salvatore Palmieri, Michela Montagna, Nicola Vianelli, Luciana Marin, Margherita Cavallin, Monica Bocchia, Marzia Defina, Micaela Ippoliti, Felicetto Ferrara, Francesca Patriarca, Maria Antonietta Avanzini, Mario Regazzi, Michele Baccarani, Miriam Isola, Franca Soldano, Renato Fanin
Publikováno v:
Haematologica, Vol 93, Iss 6 (2008)
Rituximab 375 mg/m2 weekly for four weeks has significant activity in patients with immune thrombocytopenia. We evaluated the activity of lower dose rituximab (100 mg iv weekly for 4 weeks) in 28 adults with idiopathic thrombocytopenic purpura. Overa
Externí odkaz:
https://doaj.org/article/8afb057421c044ada74cb2516caee0c1
Autor:
Pier Paolo Piccaluga, Michele Malagola, Michela Rondoni, Mario Arpinati, Stefania Paolini, Anna Candoni, Renato Fanin, Emanuela Messa, Maria Teresa Pirrotta, Francesco Lauria, Giuseppe Visani, Daniele Alberti, Francesca Rancati, Vincenza Vinaccia, Domenico Russo, Giuseppe Saglio, Michele Baccarani, Giovanni Martinelli
Publikováno v:
Haematologica, Vol 92, Iss 12 (2007)
We evaluated safety and efficacy of imatinib (600 mg) in 36 c-KIT+ acute myeloid leukemia patients not amenable to receive conventional chemotherapy. No patient achieved complete remission. One patient obtained a hematologic improvement (platelet inc
Externí odkaz:
https://doaj.org/article/1b59a6321b3d4ea3b037843e694241c3
Autor:
Emanuele Cencini, Ilaria Romano, Francesco Ghio, Chiara Camerini, Ilaria Bertaggia, Roberta Giachetti, Lara Mannelli, Maria Teresa Pirrotta, Giulia Lucco Navei, Manuel Ciceri, Giulia Cervetti, Emanuela Sant’Antonio, Federico Simonetti, Silvia Birtolo, Benedetta Puccini, Monica Bocchia, Alberto Fabbri
Publikováno v:
Annals of Hematology. 102:841-849
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51be50d8ca8da1c14f72d7f465bc7c6a
https://doi.org/10.1007/s00277-023-05113-9
https://doi.org/10.1007/s00277-023-05113-9
Daratumumab in AL Amyloidosis: A Real-Life Experience of the “RTM” (Regional Tuscan Myeloma Network)
Autor:
Gozzetti, Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini, Maria Teresa Pirrotta, Federico Perfetto, Monica Bocchia, Alessandro
Publikováno v:
Journal of Personalized Medicine; Volume 12; Issue 3; Pages: 484
Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::d4d40bacff6214b5f6c46cba1501cd24
Daratumumab in AL Amyloidosis: A Real-Life Experience of the 'RTM' (Regional Tuscan Myeloma Network)
Autor:
Vincenzo Sammartano, Elisabetta Antonioli, Gabriele Buda, Sara Ciofini, Veronica Candi, Ludovica Pengue, Maria Livia Del Giudice, Irene Attucci, Francesca Bacchiarri, Ubaldo Occhini, Maria Teresa Pirrotta, Federico Perfetto, Monica Bocchia, Alessandro Gozzetti
Publikováno v:
Journal of Personalized Medicine. 12:484
Systemic amyloidosis arises from monoclonal CD38+ plasma cells that produce misfolded immunoglobulin light chains, which form amyloid fibrils that are deposited into different tissues, leading to organ damage. Daratumumab is a human IgG/k monoclonal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c1c83ca265ed912dfab28144c43fe6
https://doi.org/10.3390/jpm12030484
https://doi.org/10.3390/jpm12030484
Publikováno v:
European Journal of Haematology. 103:442-443
Ibrutinib is an oral inhibitor of Bruton tyrosine kinase approved for the treatment of chronic lymphocytic leukaemia, mantle cell lymphoma and refractory Waldenstrom's disease. It increases progression-free survival, overall survival, response rate.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6310f897388187e1df7ecb28a6e2b6c2
https://doi.org/10.1111/ejh.13290
https://doi.org/10.1111/ejh.13290
Autor:
Patricia Hall, P.G. Hemmati, B. Dörken, David L. Diuguid, Junyuan Qi, Nikolaos Chaliasos, Masayori Hagimori, Tatjana Stojakovic, Christian Saure, L.G. Vuong, Zhou Daobin, David L. DeRemer, Dimitrios K. Bourantas, Anand Jillella, Seitaro Kamiya, Anna Challa, Maria Teresa Pirrotta, E. Bonamigo, Jun Wang, Huishu Chen, Zou Nong, Guido Kobbe, S. Neuburger, R. Sartori, Han Bing, Christian Weigelt, Jiao Li, Paulo Caleb Junior Lima Santos, Elvira Maria Guerra-Shinohara, G. Berti de Marinis, Freideriki Koutsouka, Paolo Bernardeschi, Eleftheria Hatzimichael, A. Girolami, Zhao Yong-qiang, Ernst Pilger, Dehui Zou, P. le Coutre, Yan Siyi, Alexandre C. Pereira, Antigone Siamopoulou, Gang An, Harald Froehlich, Viola Klärner, T.H. Terwey, Lars Galonska, Li Jian, Hubert Scharnagl, Masayoshi Ogasawara, José Eduardo Krieger, Nathaniel B. Langer, Wang Shujie, Peihong Zhang, Grant Lewis, Carlos S. Chiattone, R. Arnold, David E. Leaf, Druck Reinhardt Druck Basel, Celalettin Ustun, George Garratty, Xu Ying, Franz Hafner, Nihal Eisa, Rodolfo D. Cançado, Rainer Haas, Thomas Gary, I. Dokal, Zhu Tienan, Yaozhong Zhao, Alexandros Makis, Zhang Wei, S. Vettore, T. Vulliamy, Marianne Brodmann, Mohamed El-Geneidy, Robin Dobbins, Satz Mengensatzproduktion, Thomas Schroeder, Masayuki Arakawa, Shen Ti, Konstantinos L. Bourantas, Lugui Qiu, Mark Markowski, Antonios P. Vlahos, Shuhua Yi, Duan Minghui
Publikováno v:
Acta Haematologica. 124:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5a949d0057c59cfbdd23ccbc2653837
https://doi.org/10.1159/000321864
https://doi.org/10.1159/000321864
Autor:
Alessandro Gozzetti, Alfonso Cerase, Flavia Lotti, Davide Rossi, Antonio Palumbo, Maria Teresa Petrucci, Francesca Patriarca, Chiara Nozzoli, Massimo Offidani, Michele Floridia, Salvatore Berretta, Roberto Vallone, Pellegrino Musto, Francesco Lauria, for the GIMEMA Myeloma Working Party, additional authors who participated to the study: Elena Marchini, Alberto Fabbri, Stefania Oliva, Fabiana Gentilini, Stelvio Ballanti, Giuseppe Mele, Monica Galli, Maria Teresa Pirrotta, Francesco Di Raimondo, CAVO, MICHELE, ZAMAGNI, ELENA
BACKGROUND: Intracranial involvement in multiple myeloma is extremely rare. The effect of new drugs (eg, thalidomide, bortezomib, lenalidomide) with respect to old drugs (eg, alkylators, steroids) has not been reported. METHODS: We collected clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00cf17fa07f69ea6feabf78e5b71a343
http://hdl.handle.net/11585/118925
http://hdl.handle.net/11585/118925
Autor:
Monica Bocchia, Alessandro Bucalossi, Alessandro Gozzetti, Marzia Defina, Francesco Lauria, Maria Teresa Pirrotta, Francesco Forconi
Publikováno v:
Acta Haematologica. 118:7-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6a5ceb36e0d2dac27b2bc5c827b426f
https://doi.org/10.1159/000100992
https://doi.org/10.1159/000100992
Autor:
Maria Teresa Pirrotta, P. Bernardeschi
Publikováno v:
Acta haematologica. 124(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6574b23b0190845525e3b31c0312bdb
https://pubmed.ncbi.nlm.nih.gov/21071932
https://pubmed.ncbi.nlm.nih.gov/21071932